Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SCXA antibody (C-Term)

The Rabbit Polyclonal anti-SCXA antibody has been validated for WB and ELISA. It is suitable to detect SCXA in samples from Human.
Catalog No. ABIN2356832

Quick Overview for SCXA antibody (C-Term) (ABIN2356832)

Target

See all SCXA Antibodies
SCXA (Scleraxis (SCXA))

Reactivity

  • 28
  • 25
  • 13
Human

Host

  • 26
  • 2
Rabbit

Clonality

  • 27
  • 2
Polyclonal

Conjugate

  • 11
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This SCXA antibody is un-conjugated

Application

  • 17
  • 11
  • 8
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA
  • Binding Specificity

    • 13
    • 7
    • 3
    • 2
    • 2
    • 1
    AA 179-209, C-Term

    Cross-Reactivity

    Human, Mouse (Murine)

    Cross-Reactivity (Details)

    Calculated cross reactivity: Hu Mo

    Characteristics

    SCXA, CT (SCXA, BHLHA41, SCX, Basic helix-loop-helix transcription factor scleraxis, Class A basic helix-loop-helix protein 41, Class A basic helix-loop-helix protein 48)

    Purification

    Purified by Protein A affinity chromatography.

    Immunogen

    SCXA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 179-209 amino acids from the C-terminal region of human SCXA.

    Isotype

    IgG
  • Application Notes

    Optimal working conditions should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    -20°C
  • Target

    SCXA (Scleraxis (SCXA))

    Alternative Name

    SCXA

    NCBI Accession

    NP_001073983, NP_001008272

    UniProt

    Q7RTU7
You are here:
Chat with us!